Ibrexafungerp citrate (MK 3118 citrate) is an orally active beta-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp citrate is an investigational agent for the treatment of Candida and Aspergillus infections[1].
Molecular Weight:
922.16
Purity:
99.1
CAS Number:
[1965291-08-0]
Formula:
C50H75N5O11
Target:
Fungal
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted